Skip to main content
OpenTrials

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

6,023 public trials 1,221 recruiting studies
Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Suspended

Testing a New Immune Cell Therapy, GD2-Targeted Modified T-cells (GD2CART), in Children, Adolescents, and Young Adults With Relapsed/Refractory Osteosarcoma and Neuroblastoma, GD2-CAR PERSIST Trial

NCT04539366

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Bone Tissue, +20 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
View Trial Details
Suspended

Anti-Lag-3 (Relatlimab) and Anti-PD-1 Blockade (Nivolumab) Versus Standard of Care (Lomustine) for the Treatment of Patients With Recurrent Glioblastoma

NCT06325683

Conditions
Astrocytoma, Glioblastoma, Glioma, +9 more
Locations
  • NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro Jonesboro, Arkansas, United States
  • Sutter Auburn Faith Hospital Auburn, California, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Kaiser Permanente Dublin Dublin, California, United States
View all 325 locations
View Trial Details

Related conditions